Induction with infliximab and a plant-based diet as first-line (IPF) therapy for moderate-to-severe to severe ulcerative colitis

被引：0

作者：

Chiba, Mitsuro ^{[1
]}

Nakane, Kunio ^{[1
]}

Tsuji, Tsuyotoshi ^{[1
]}

Tsuda, Satoko ^{[1
]}

Ishii, Hajime ^{[1
]}

Ohno, Hideo ^{[1
]}

Watanabe, Kenta ^{[1
]}

Ito, Mai ^{[1
]}

Obara, Yu ^{[1
]}

Komatsu, Masafumi ^{[1
]}

Sugawara, Takeshi ^{[2
]}

机构：

[1] Akita City Hosp, Dept Internal Med GI Hepatol, Akita, Japan

[2] Nakadori Gen Hosp, Dept Internal Med GI Hepatol, Akita, Japan

来源：

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2018年 / 33卷

关键词：

ulcerative colitis; infliximab; plant-based diet; remission; inflammatory bowel disease;

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

OE-0103 (P

引用

页码：483 / 483

页数：1

共 50 条

[31] Vedolizumab versus adalimumab for moderate-to-severe ulcerative colitis
Tribich, Samuel
Maurice, James
[J]. FRONTLINE GASTROENTEROLOGY, 2020, 11 (02) : 173 - 173
[32] Safety evaluation of ustekinumab for moderate-to-severe ulcerative colitis
Miyoshi, Jun
Matsuura, Minoru
Hisamatsu, Tadakazu
[J]. EXPERT OPINION ON DRUG SAFETY, 2022, 21 (01) : 1 - 8
[33] Pharmacokinetics of golimumab in patients with moderate-to-severe ulcerative colitis
Berends, S.
Strik, A.
van Egmond, P.
Brandse, H.
Mathot, R.
D'Haens, G.
Lowenberg, M.
[J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S424 - S424
[34] Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
Sands, Bruce E.
Peyrin-Biroulet, Laurent
Loftus, Edward V., Jr.
Danese, Silvio
Colombel, Jean-Frederic
Toruner, Murat
Jonaitis, Laimas
Abhyankar, Brihad
Chen, Jingjing
Rogers, Raquel
Lirio, Richard A.
Bornstein, Jeffrey D.
Schreiber, Stefan
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (13): : 1215 - 1226
[35] Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
O'Connor, Donal B.
Lahiff, Conor
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (01): : 92 - 93
[36] A CASE OF SUCCESSFUL INDUCTION OF REMISSION IN MODERATE-TO-SEVERE STEROID REFRACTORY ULCERATIVE COLITIS USING HERBAL THERAPY
Lee, Alice
Mandaliya, Rohan
Mattar, Mark C.
[J]. GASTROENTEROLOGY, 2018, 154 (01) : S91 - S91
[37] A CASE OF SUCCESSFUL INDUCTION OF REMISSION IN MODERATE-TO-SEVERE STEROID REFRACTORY ULCERATIVE COLITIS USING HERBAL THERAPY
Lee, Alice
Mandaliya, Rohan
Mattar, Mark C.
[J]. INFLAMMATORY BOWEL DISEASES, 2018, 24 : S64 - S64
[38] Cost-effectiveness of immunomodulators versus infliximab for adults with moderate-to-severe ulcerative colitis.
Malone, D.
Hurwitz, J.
Lofland, J.
Nejadnik, B.
Vanderpoel, J.
Waters, H.
[J]. INFLAMMATORY BOWEL DISEASES, 2011, 17 : S53 - S54
[39] Addition of leukocytapheresis to steroid therapy - Is it beneficial in recurrence of moderate-to-severe ulcerative colitis?
Jo, Y
Matsumoto, T
Mibu, R
Iida, M
[J]. DISEASES OF THE COLON & RECTUM, 2003, 46 (10) : S3 - S9
[40] Infliximab as first-line therapy for severe Crohn's disease?
Cohen, RD
[J]. INFLAMMATORY BOWEL DISEASES, 2002, 8 (01) : 58 - 59

← 1 2 3 4 5 →